102 Alternatively, several teams are advocating for your incorporation of novel markers, such as a advanced karyotype55 or epigenetic subsets, 27,28 into medical practice. All these novel prognostic and/or predictive types will should be validated in cohorts of sufferers addressed with targeted agen